Axcella Health Stock Is Skyrocketing: What's Going On?
Portfolio Pulse from Adam Eckert
Axcella Health Inc's shares are soaring after the company was granted a patent for long COVID fatigue treatment. The U.S. Patent and Trademark Office granted Axcella a patent covering methods of use of AXA1125 for treating long COVID, particularly fatigue. The patent was issued Tuesday and has an expected expiration in 2042.
August 29, 2023 | 1:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Axcella Health Inc's stock is rising after the company was granted a patent for long COVID fatigue treatment. The patent covers the use of AXA1125 and is expected to expire in 2042.
The news of Axcella Health Inc being granted a patent for long COVID fatigue treatment is directly related to the company and its stock. This is a positive development for the company as it provides a competitive advantage and potential for increased revenues in the future. Therefore, it is expected to have a positive impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100